Megestrol (Megestrol Acetate) - Summary

MEGESTROL SUMMARY

MEGESTROL ACETATE Oral Suspension USP

Megestrol Acetate Oral Suspension USP contains megestrol acetate, a synthetic derivative of the naturally occurring steroid hormone, progesterone.

Megestrol Acetate Oral Suspension USP is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).

MEGESTROL NEWS HIGHLIGHTS

Published Studies Related to Megestrol

Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. [2008.04.01]

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: a randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C). [2008]

Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. [2007.02]

Megestrol attenuates the hormonal response to CCK-4-induced panic attacks. [2006]

Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. [2005.07]

more>>

Clinical Trials Related to Megestrol

Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-Related Weight Loss [Completed]

Effect of Renal Impairment on the Pharmacokinetics, and Safety of Megestrol Acetate Concentrated Suspension [Terminated]

Evaluating the Effect of Food on Absorption of Megace ES [Completed]

Treatment of Cancer-Associated Anorexia Using Megestrol Acetate Concentrated Suspension [Terminated]

Treatment of Cancer-Anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients [Terminated]

more>>